T1	Participants 129 146	Hodgkin's disease
T2	Participants 418 518	HD patients in stage I to IIIA with a large mediastinal mass, E stage, or massive spleen involvement
T3	Participants 802 844	146 patients who responded to chemotherapy
T4	Participants 872 891	20 Gy (70 patients)
T5	Participants 895 914	40 Gy (76 patients)
T6	Participants 988 1109	111 patients who fulfilled the same inclusion criteria in the subsequent trial HD5 (1988 to 1993) were treated with 30 Gy
T7	Participants 1111 1147	Bulky disease always received 40 Gy.
T8	Participants 1813 1848	patients with intermediate-stage HD
